Profile
| Metric | Value |
|---|---|
| Full Name | agilon health, inc. |
| Ticker | NYSE: AGL |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | agilonhealth.com |
| Employees | 1,076 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.99 | |
| Price, 1D Change | -1.88% | |
| Market Cap | $411M | |
| - | ||
| PE Ratio | - | |
| Beta | 0.20 | |
| Revenue | $6B | |
| Revenue, 1Y Change | +40.41% | |
| EPS | -$0.61 | |
| EPS, 1Y Change | -16.31% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.61 | |
| EPS Estimate | -$0.74 | |
| EPS Est. Change | -21.35% | |
| Revenue | $6.06B | |
| Revenue Estimate | $5.82B | |
| Revenue Est. Change | -3.91% | |
| Current Price | $0.99 | |
| Price Target | - | $1.00 |
| Price Tgt. Change | - | +0.91% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.36 | -$0.53 | -46.08% | |
| -$0.29 | -$0.61 | -112.32% | |
| -$0.74 | N/A | -21.35% | |
| -$0.41 | N/A | +32.58% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.49B | $4.32B | -3.84% | |
| $6.06B | $6.06B | +0.08% | |
| $5.82B | N/A | -3.91% | |
| $5.98B | N/A | -1.31% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -73.14% | |
| Price, 3Y | -95.17% | |
| Market Cap, 1Y | -72.99% | |
| Market Cap, 3Y | -95.14% | |
| Revenue, 1Y | +40.41% | |
| Revenue, 3Y | +230.53% | |
| EPS, 1Y | -16.31% | |
| EPS, 3Y | +39.86% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.99 | |
| SMA 200 | $1.69 | |
| SMA 200 vs Price | +70.76% | |
| SMA 50 | $0.73 | |
| SMA 50 vs Price | -25.91% | |
| Beta | 0.20 | |
| ATR | $0.07 | |
| 14-Day RSI | 63.29 | |
| 10-Day Volatility | 73.91% | |
| 1-Year Volatility | 103.26% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $6.06B | |
| EPS | -$0.61 | |
| Gross Profit | $4.84M | |
| Gross Margin | 0.08% | |
| Operating Profit | -$288.53M | |
| Operating Margin | -4.76% | |
| Net Income | -$250.28M | |
| Net Margin | -4.29% | |
| EBITDA | -$218.19M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.07 | |
| Current Ratio | 1.27 | |
| 1.27 | ||
| Interest Coverage | -39.28 | |
| F-Score | 3 | |
| Altman Z-Score | 2.16 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 0.07 | |
| PB Ratio | 1.34 | |
| EV/EBITDA | -0.40 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $470.95M | |
| Cash & Equivalents | $188.23M | |
| Total Assets | $1.73B | |
| Current Assets | $1.46B | |
| Total Liabilities | $1.26B | |
| Current Liabilities | $1.15B | |
| Total Debt | $43.96M | |
| Short Term Debt | $2.46M | |
| Accounts Payable | $1.15B |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $6.35B | |
| Operating Expenses | $293.38M | |
| Cost Of Goods Sold | $6.06B | |
| SG&A | $268.91M | |
| D&A | $24.46M | |
| Interest Expense | $6.18M | |
| Income Tax | $1.45M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$57.78M | |
| CFI | $139.89M | |
| CFF | -$2.58M | |
| Capex | $41.29M | |
| Free Cash Flow | -$99.06M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Wells Fargo | → | |
| Wells Fargo | → | |
| Bernstein | → | |
| Jefferies | → | |
| Baird | → | |
| Citigroup | → | |
| Benchmark | → | |
| Barclays | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
Screeners with AGL
FAQ
What is the ticker symbol for agilon health, inc.?
The ticker symbol for agilon health, inc. is NYSE:AGL
Does agilon health, inc. pay dividends?
No, agilon health, inc. does not pay dividends
What sector is agilon health, inc. in?
agilon health, inc. is in the Healthcare sector
What industry is agilon health, inc. in?
agilon health, inc. is in the Medical Care Facilities industry
What country is agilon health, inc. based in?
agilon health, inc. is headquartered in United States
When did agilon health, inc. go public?
agilon health, inc. initial public offering (IPO) was on April 15, 2021
Is agilon health, inc. in the S&P 500?
No, agilon health, inc. is not included in the S&P 500 index
Is agilon health, inc. in the NASDAQ 100?
No, agilon health, inc. is not included in the NASDAQ 100 index
Is agilon health, inc. in the Dow Jones?
No, agilon health, inc. is not included in the Dow Jones index
When was agilon health, inc. last earnings report?
agilon health, inc.'s most recent earnings report was on November 4, 2025
When does agilon health, inc. report earnings?
The next expected earnings date for agilon health, inc. is February 24, 2026
Data Sources & References
- AGL Official Website www.agilonhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1831097/000162828025048839/0001628280-25-048839-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1831097/000162828025007721/0001628280-25-007721-index.htm
- AGL Profile on Yahoo Finance finance.yahoo.com/quote/AGL
- AGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agl